InvestorsHub Logo
Followers 34
Posts 2986
Boards Moderated 0
Alias Born 02/27/2016

Re: Jonjones325 post# 188407

Friday, 04/05/2019 6:34:29 PM

Friday, April 05, 2019 6:34:29 PM

Post# of 457568
A little more. He said he thinks that 2-73 would work on Schizophrenia but we don't have money for all these trials so we're piggy backing on ERP to be involved but not invest in a trial.

He said if we had the money, we'd be running a ton of trials.

He also said that we might get our own sales team for Rett for since it's a manageable sized market but due to the massive size of Alz and PDD, we'll need a partner.

If he didn't expect success, he wouldn't be talking about commercialization and wouldn't waste good money on stockpiling a supply for it. IMO of course.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AVXL News